Furthermore, EA exerted an effect that was similar to P2Y12 shRNA in that it caused a significant downregulation in the expression levels of P2Y12, attenuated microglia activation, and subsequently inhibited the levels of interleukin-1beta in the mPFC, thus alleviating visceral pain and depression in IBD mice. Here, P2RY12 is linked to irritable bowel syndrome.